Table 2 The interaction term of VEGF levels and chemotherapy arms in EGFR-WT patients

From: Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC

 

P value for interaction

Chemotherapy and tVEGF-A

0.0177

Chemotherapy and VEGF121

0.0384

Chemotherapy and VEGF165

0.0763

Back to article page